Skip to main content
OpenTrials

Clinical trial condition

Thyroid Diseases

Explore clinical trials studying Thyroid Diseases. Study availability and eligibility vary by location and protocol.

1,049 public trials 244 recruiting studies
Refine in advanced search Browse all conditions

Thyroid Diseases trial results

Completed

Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer

NCT02393690

Conditions
Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +22 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Hoag Memorial Hospital Newport Beach, California, United States
  • University of Colorado Hospital Aurora, Colorado, United States
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
View Trial Details
Completed

Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations

NCT02383927

Conditions
Carcinoma, Carcinoma, Squamous Cell, Endocrine Gland Neoplasms, +13 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • Wihship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
View all 35 locations
View Trial Details
Completed

Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study

NCT03298867

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +13 more
Locations
  • Macro, Llc Beverly Hills, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • The Lennar Foundation Medical Coral Gables, Florida, United States
  • Bascom Palmer Eye Institute Miami, Florida, United States
View all 14 locations
View Trial Details
Completed

A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye Disease

NCT04583735

Conditions
Autoimmune Diseases, Behavior, Bronchial Diseases, +25 more
Locations
  • The Private Practice of Raymond Douglas Beverly Hills, California, United States
  • Perlman Medical Offices / UCSD La Jolla, California, United States
  • MACRO Trials Los Angeles, California, United States
  • Univ of Colorado Dept of Ophthalmology Aurora, Colorado, United States
View Trial Details
Completed

Treatment of Graves' Orbitopathy to Reduce Proptosis With Teprotumumab Infusions in an Open-Label Clinical Extension Study

NCT03461211

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Macro, Llc Beverly Hills, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Bascom Palmer Eye Institute Miami, Florida, United States
  • Kellogg Eye Center at University of Michigan Ann Arbor, Michigan, United States
View all 13 locations
View Trial Details
Completed

A Study of TEPEZZA® Treatment in Participants With Thyroid Eye Disease

NCT06389578

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Bascom Palmer Eye Institute - University of Miami Miami, Florida, United States
  • Barnes Jewish Hospital Washington University St Louis, Missouri, United States
  • Neuro-Eye Clinical Trials Bellaire, Texas, United States
View Trial Details

Related conditions